These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21605857

  • 1. Letrozole and gonadotropins versus luteal estradiol and GnRH-antagonist protocol: additional concerns.
    Wiwanitkit V.
    Fertil Steril; 2011 Jun 30; 95(8):e78; author reply e80. PubMed ID: 21605857
    [No Abstract] [Full Text] [Related]

  • 2. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A, Engmann L, Nulsen J, Benadiva C.
    Fertil Steril; 2011 Jun 30; 95(7):2330-4. PubMed ID: 21514582
    [Abstract] [Full Text] [Related]

  • 3. Discussion on letrozole-Gn-antagonist group needing an early start of antagonist.
    Chen X.
    Fertil Steril; 2011 Jun 30; 95(8):e79; author reply e80. PubMed ID: 21605860
    [No Abstract] [Full Text] [Related]

  • 4. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.
    Fouda UM, Sayed AM.
    Gynecol Endocrinol; 2011 Dec 30; 27(12):1018-22. PubMed ID: 21714697
    [Abstract] [Full Text] [Related]

  • 5. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L, Noriega-Hoces L, Delgado A, Rubio J, Gonzales-Castañeda C, Gonzales GF.
    Fertil Steril; 2008 Nov 30; 90(5):1818-25. PubMed ID: 18083169
    [Abstract] [Full Text] [Related]

  • 6. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
    Mohsen IA, El Din RE.
    Gynecol Endocrinol; 2013 Feb 30; 29(2):105-8. PubMed ID: 23134528
    [Abstract] [Full Text] [Related]

  • 7. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O, Gervy C, Englert Y, Delbaere A, Demeestere I.
    Hum Reprod; 2015 Sep 30; 30(9):2184-9. PubMed ID: 26109617
    [Abstract] [Full Text] [Related]

  • 8. Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase: A Randomized Controlled Trial.
    Maged AM, Nada AM, Abohamila F, Hashem AT, Mostafa WA, Elzayat AR.
    Reprod Sci; 2015 Dec 30; 22(12):1627-31. PubMed ID: 26045549
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
    DiLuigi AJ, Engmann L, Schmidt DW, Benadiva CA, Nulsen JC.
    Fertil Steril; 2011 Jun 30; 95(8):2531-3. PubMed ID: 21324455
    [Abstract] [Full Text] [Related]

  • 10. Use of letrozole challenge test to adjust gonadotropin dose in non-down-regulated cycles.
    Bentov Y, Burstein E, Esfandiari N, Casper RF.
    Fertil Steril; 2011 Jun 30; 95(8):2492-3. PubMed ID: 21481375
    [Abstract] [Full Text] [Related]

  • 11. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM, Muasher SJ.
    Fertil Steril; 2011 Jun 30; 95(8):2449-55. PubMed ID: 21550037
    [Abstract] [Full Text] [Related]

  • 12. Five-day anastrozole group in infertility needs supplemental human chorionic gonadotropin.
    Chen X.
    Fertil Steril; 2011 Aug 30; 96(2):e135; author reply e136. PubMed ID: 21683349
    [No Abstract] [Full Text] [Related]

  • 13. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
    Olgan S, Humaidan P.
    Reprod Biol; 2017 Mar 30; 17(1):105-110. PubMed ID: 28173995
    [Abstract] [Full Text] [Related]

  • 14. GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization.
    Davar R, Oskouian H, Ahmadi S, Firouzabadi RD.
    Taiwan J Obstet Gynecol; 2010 Sep 30; 49(3):297-301. PubMed ID: 21056314
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.
    Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z.
    Fertil Steril; 2011 Feb 30; 95(2):592-5. PubMed ID: 21074154
    [Abstract] [Full Text] [Related]

  • 16. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK.
    Fertil Steril; 2008 Jan 30; 89(1):151-6. PubMed ID: 17482177
    [Abstract] [Full Text] [Related]

  • 17. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
    Wei LH, Ma WH, Tang N, Wei JH.
    Taiwan J Obstet Gynecol; 2016 Feb 30; 55(1):50-4. PubMed ID: 26927248
    [Abstract] [Full Text] [Related]

  • 18. The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients.
    Ozcan Cenksoy P, Ficicioglu C, Kizilkale O, Suhha Bostanci M, Bakacak M, Yesiladali M, Kaspar C.
    Gynecol Endocrinol; 2014 Jul 30; 30(7):485-9. PubMed ID: 24592985
    [Abstract] [Full Text] [Related]

  • 19. A comparison of letrozole to gonadotropins for ovulation induction in subjects with advanced maternal age: a retrospective pilot study.
    Dahan MH, Quintero RB, Urban R.
    Fertil Steril; 2008 Oct 30; 90(4):1226-8. PubMed ID: 18061174
    [Abstract] [Full Text] [Related]

  • 20. The dawning of the non-cancer uses of aromatase inhibitors in gynaecology.
    de Ziegler D.
    Hum Reprod; 2003 Aug 30; 18(8):1598-602. PubMed ID: 12871868
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.